Bayesian sequential monitoring strategies for trials of digestive cancer therapeutics

Abstract Background New therapeutics in oncology have presented challenges to existing paradigms and trial designs in all phases of drug development. As a motivating example, we considered an ongoing phase II trial planned to evaluate the combination of a MET inhibitor and an anti-PD-L1 immunotherap...

Full description

Saved in:
Bibliographic Details
Main Authors: Guillaume Mulier, Ruitao Lin, Thomas Aparicio, Lucie Biard
Format: Article
Language:English
Published: BMC 2024-07-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:https://doi.org/10.1186/s12874-024-02278-3
Tags: Add Tag
No Tags, Be the first to tag this record!